Background: This systematic review seeks to evaluate the role of epicardial adipose tissue
INTRODUCTION
Acute coronary syndromes remain a leading cause of death worldwide despite the many advances in both preventive strategies and emergency treatment options, including percutaneous coronary interventions. 1 Several predictors of the severity of coronary artery disease have been established, and, in recent years, attention has been directed towards the role of epicardial adipose tissue (EAT) as a cardiovascular risk factor, as well as the assessment of instability of atherosclerotic coronary plaques. 2 
EAT -rolE And pAThophysiology
Adipose tissue surrounding the heart has several roles, including being an energy provider for myocardial metabolism, thermoregulation, and mechanical protection for both the epicardial coronary vessels and the autonomic innervation of the heart. 3 The metabolic and immunologic effects of EAT remain unclear, although several hypotheses have been suggested, including that of secreting increased quantities of anti-and pro-inflammatory cytokines, regulating the oxidative reactions within the myocardial fibers, as well as influencing the contractility, conductibility, and excitability of the heart. 4 Furthermore, being a visceral fat and having the same characteristics and behavior as intra-abdominal fat, EAT appears to be one of the extra-vascular culprits associated with the progression and aggravation of atherosclerotic lesions. 5 The genesis of a coronary atheroma is influenced, in various stages, by the adipose tissue surrounding the heart, from intimal malfunction at an early stage, to plaque erosion and rupture, with subsequent thrombosis and the occurrence of an acute coronary syndrome. 6, 7 Histopathological studies of epicardial fat samples acquired during cardiac surgery have shown that EAT contains several inflammation biomarkers, including tumor necrosis factor-α, interleukins, and chemokines, which might contribute to the development and progression of insulin resistance, and also enhance apoptosis within the coronary plaque and vessel inflammation. 8 On the other hand, epicardial adipose tissue has beneficial effects by secreting adiponectin -with anti-inflammatory and anti-atherogenic properties and also by stimulating neo-angiogenesis in subjects with chronic coronary occlusions. 8, 9 EAT in coronAry AThErosclErosis
And AcuTE coronAry syndromEs
EAT has been shown to be linked with the presence and severity of coronary atherosclerotic lesions. 10, 11 Subjects with an increased EAT, assessed either by echocardiography or cardiac CT, have a more severe extension of coronary atherosclerosis, and EAT is also linked to the overall plaque burden and cardiovascular risk factors. [12] [13] [14] Furthermore, the incidence of myocardial infarction seems to be directly proportional to the increase in epicardial fat, which is also related to a higher rate of major adverse cardiovascular events in subjects with known coronary artery disease (CAD). 15, 16 Due to its paracrine properties, by secreting serum inflammatory biomarkers EAT brings a significant contribution to the vulnerability of the coronary atheromatous plaque, either by local inflammation or by stimulating neo-angiogenesis and the development of vasa-vasorum and subsequent intra-plaque hemorrhage, plaque rupture and thrombosis. 15, 17, 18 Patients without chest pain who present with major adverse cardiovascular events have a bigger epicardial fat volume compared to event-free patients. 19 The coronary artery calcium score, a marker of CAD severity, has a positive correlation with EAT in patients with both obstructive and non-obstructive
CAD. An increased EAT volume, together with low attenuation plaques with the presence of a napkin-ring sign, are correlated with a higher risk of future acute coronary events in non-obese subjects. 20, 21 Moreover, the thickness of the epicardial fat has been shown to be closely linked to the presence of multi-vessel CAD in patients with acute myocardial infarction.
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EAT -mEThods of AssEssmEnT
And imAging TEchniquEs
The imaging methods for assessing epicardial fat include 
MATERIALS AND METHOD
sEArch sTrATEgy
The study was conducted in agreement with the PRISMA methodology (Preferred Reporting Items for Systematic
Reviews and Meta-Analyses). 
dATA ExTrAcTion And AnAlysis
The two investigators extracted the following data from the selected manuscripts: the number of subjects included in the study, age, gender, type of acute coronary syndrome for which they had been admitted, the follow-up period, the primary and secondary endpoints, the method of assessment of EAT, the mean values (TTE) and volume (cardiac CT) of EAT respectively, as well as the presence of diabetes, smoking, hypertension history, obesity. Furthermore, whenever available, data extraction included the odds ratios (OR) and hazard ratios (HR) when appropriate for the endpoints of each study.
sTudy quAliTy AssEssmEnT And EligibiliTy condiTions
No study was excluded for motives of decreased study quality, but the selected studies presented a concise portrayal of the inclusion and exclusion criteria, the endpoints and the follow-up periods, as well as a precise method for assessing the EAT, irrespective of the noninvasive method that had been used (TTE or cardiac CT).
Articles that enrolled only subjects with stable CAD were excluded from the search. Also, we excluded various articles such as case reports, case series, reviews, editorials, letters, as well as manuscripts that were not available in full-text form. The search filter also excluded species other than humans.
RESULTS
One-hundred forty-four manuscripts were screened in total, out of which 56 were identified using the described search strategy and were reviewed in a full-text form.
From those, 47 studies were excluded for not meeting the inclusion criteria. These were either reviews or metaanalyses, the study cohorts included only stable coronary artery disease patients, or they did not state a clear and concise study design, endpoints or follow-up ( Figure 1 ).
The final draft included nine studies for systematic evaluation: one study that used CT for EAT assessment, and eight manuscripts that assessed EAT with TTE.
In all, 2,306 patients were included, of which 170 subjects underwent cardiac CT for EAT evaluation, 37 while the remaining 2,136 patients underwent TTE measure-ment of EAT. [38] [39] [40] [41] [42] [43] [44] [45] Table 1 presents a summary of the included manuscripts. All systematized manuscripts contain a concise and clear portrayal of the inclusion and exclusion criteria and the method for assessing EAT, either through cardiac CT or TTE (Table 1 ). All studies enrolled patients with acute coronary syndromes. Six of the nine studies used, as one of the main exclusion criteria, previous revascularization therapies, either by coronary artery bypass grafting or percutaneous coronary intervention.
chArAcTErisTics of ThE sTudy populATions
The overall characteristics of the patients included in the nine study cohorts, including cardiovascular risk factors and gender distribution, are listed in Table 2 .
sTATisTicAl AnAlysis And sTudy dEsign of ThE sElEcTEd mAnuscripTs
There was a diversity of study methodology and statistical approaches used in the selected manuscripts. Four studies were retrospective and calculated odds ratios based on multivariate logistic regression. From the five prospective observational studies, only one used Cox proportional hazards models for the prediction of major adverse cardiovascular events (MACE) rates during the three-year follow-up. 42 Most researchers (n = 6) used the Receiver Operator Characteristics (ROC) curve and the area under the curve for the determination of the cut-off value for EAT values that predicted the study outcome. [37] [38] [39] [40] [41] 45 All selected articles used Spearman or Pearson correlation coefficient statistics for evaluating the link between epicardial fat and other clinical and laboratory variables.
sTudy EndpoinTs And rEsEArch hypoThEsEs
EAT and MACE
Two manuscripts examined the prognostic value of EAT, and the endpoints included the in-hospital MACE rates. 40 One study42 had a three-year follow-up period, with major adverse cardiovascular events as a primary endpoint. EFV -epicardial fat volume (ml); EFT -epicardial fat thickness; CABG -coronary by-pass grafting; PCI -percutaneous coronary intervention; CAD -coronary artery disease; ACS -acute coronary syndromes; CKD -chronic kidney disease; BMI-body mass index; TTE -transthoracic echocardiography; MBG -myocardial blush grade; TCF -thrombolysis in myocardial infarction frame count; IRA -infarct-related artery; USAP -unstable angina pectoris. Studies that assess the EFV (ml) by using cardiac CT Harada et al. 
EAT and ACS risk scores
Seven manuscripts evaluated the correlation between EAT
(measured with TTE) and various ACS risk scores (Table   4) . [38] [39] [40] [41] [43] [44] [45] Zencirci et al. (2014) hypothesized that there is an inverse association between the EAT and the STsegment resolution following primary PCI for acute STE-MI. 45 Other studied risk scores are the SYNTAX score for coronary atherosclerosis severity, the GRACE and TIMI risk scores for survival following an acute cardiac event,
and also indicators for coronary perfusion after PCI (TIMI flow, myocardial blush grade -MBG, and TIMI frame count -TFC) ( CT and compared epicardial fat volume (EFV, ml) in subjects with ACS (n = 80) and controls (n = 90). There was no significant coronary artery stenosis, and healthy individuals had a significantly lower EFV compared to the case lot (p <0.001). showed that patients with AMI have a significantly higher EAT thickness compared to unstable angina or stable CAD patients (p <0.001) 39 (Table 5) .
EAT assessed by TTE was variable among study measurements, the mean ranging from a minimum of 2.65 mm, to a maximum of 8.5 ± 1.4 mm ( Table 5) .
DISCUSSIONS
Although study design in the available research articles was not constant, the prognostic value of EAT in ACS and the possible correlations between EAT and ACS risk scores and coronary perfusion indicators were appraised. Despite not being consistent, the results indicated that EAT tends to negatively impact the outcome, the risk of further adverse events, and the success of coronary revascularization procedures.
The role of epicardial fatty tissue has been extensively studied, and its pathophysiology is now better known,
showing both positive and negative bearings on the development and progression of CAD. GRACE -global registry of acute coronary events risk score; SYNTAX -; MGB -myocardial blush grade; TFC -TIMI frame count; nr -not reported; TIMI RS -thrombolysis in myocardial infarction risk score; PCI -percutaneous coronary intervention; ΔSTR -difference between the sum of ST segment elevations before and after revascularization
There is evidence that EAT is in direct relation with the body mass index and the presence of obesity, and it is also increased in patients with metabolic syndromes. 32, [46] [47] [48] Epicardial fat has also been linked to an increased systemic inflammatory status in type 2 diabetes patients with acute myocardial infarction, and in patients with a higher EAT thickness it was associated with an enhanced left ventricular remodeling process and lower ejection fraction at six months. 49 Further studies are needed to elucidate the effect of a reduction of EAT on risk diminution, although some researchers have proved that the regression of EF can be achieved with weight loss measures, dietary modifications, regular physical exercise, and lipid-lowering therapies with statins and ezetimibe.
28,50-52
Coronary artery plaque burden was shown to be associated with a higher quantity of epicardial fat. 53 Several studies have stated that there is a relationship between an increased EAT and plaque vulnerability. [54] [55] [56] Noninvasive imaging biomarkers, identified by computed tomography coronary angiography, include the coronary artery calcium score, low-density plaques with an increased necrotic core, the presence of spotty calcifications and the napkinring sign. 57, 58 Biomarkers for plaque instability, detected by advanced imaging methods such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT)
include the thick fibrous cap atheroma, fibrous cap thickness, the extent of intra-plaque macrophage deposition, vessel extension and rupture. [59] [60] [61] Two of the largest EAT studies included cohorts of patients with no cardiovascular disease. The MESA trial/ study showed a positive association between the coronary artery calcium score and the EFV assessed by CT, but the Heinz-Nixdorf Recall study found that EAT predicted an excessive risk for coronary events, independently of the calcium score and classic cardiovascular risk factors. 15, 62 The studies analyzed in our systematic review did not include manuscripts that had evaluated coronary calcium or vulnerable plaque biomarkers, as these did not meet the inclusion criteria.
EAT And Acs risk scorEs
Ongoing research is being undertaken to identify additional risk markers which could predict future cardiovas- na -not available; STEMI -ST-elevation myocardial infarction; NSTEMI -non-ST elevation myocardial infarction; USAP -unstable angina pectoris; ACS -Acute coronary syndrome; SAP -stable angina pectoris; EF -epicardial fat assessed either as volume (ml) or as thickness (mm); * Controls -patients with no significant coronary artery stenosis, with or without chest pain. ** The study analysed patients with acute myocardial infarction without differentiating between STEMI and NSTEMI patients, the mean EF is expressed for the total AMI patients (STEMI+NSTEM) *** AMI includes both STEMI and NSTEMI.
Our systematic analysis showed that several investigations have studied the correlation between EAT thickness and established ACS risk scores. 38, [43] [44] [45] One study 43 found a significant association between EAT and GRACE scores (p <0.001), though this was not corroborated by other studies. 38 The angiographic SYNTAX score for coronary lesion severity and the clinical TIMI risk score for adverse coronary events were also found to be significantly linked with EAT. 38, 40, 44 Being associated with ACS severity and risk prediction scores and connected with markers that express an increased patient vulnerability for acute coronary syndromes, at the same time being proven as an independent CAD, 53 EAT qualifies as a candidate for inclusion in current ACS risk scores.
One of the included studies hypothesized that an increased thickness of the epicardial fat is linked to impairment in the ST-segment resolution following revascularization in acute MI patients. 45 ST-segment resolution is a surrogate for tissue level reperfusion, illustrating the no-reflow phenomenon after primary PCI, and the lack of ST-segment regression after PCI has been proved to be a predictor for in-hospital mortality rates. 
66,67
EAT And mAjor AdvErsE cArdiovAsculAr EvEnTs
sTudy limiTATions
Although initially we sought to conduct a systematic review of studies that assessed EAT using echocardiography in comparison with cardiac CT, in the course of our search we found that there were few studies that used CT in emergency clinical settings for diagnosing and managing acute coronary syndromes.
Secondly, cut-off values for epicardial fat have not been reproduced, due mainly to the fact that there are assorted descriptions of EF aggregation reported in the literature.
The power of this systematic review, in common with similar studies, is limited by the quality of the incorporated manuscripts, the study designs, and the statistical methods that had been used.
Regardless of these limitations, we are of the opinion that the study provides insights into the role of EAT in diagnosing and managing patients with acute coronary syndromes.
CONCLUSIONS
Epicardial adipose tissue, evaluated either by thickness using echocardiography, or by volume using cardiac CT, is associated with the severity of coronary stenosis, with the clinical and angiographic risk scores for acute coronary syndromes, and also with indicators of coronary reperfusion. Information provided by epicardial fat tissue can be used as predictors of major cardiovascular events in patients with acute coronary syndromes, over both short and long term.
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